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Background. Intraatrial reentrant tachycardia (IART) is a
common problem in patients with congenital heart disease
(CHD). The progression of clinical symptoms of IART and their
response to radiofrequency (RF) ablation are not yet well de-
scribed.
Objectives. The objective of the study was to determine the early
and midterm success rates of RF ablation in effecting a reduction
of clinical arrhythmic events in patients with IART and CHD.
Methods. Clinical records of patients undergoing early, suc-
cessful RF ablation were analyzed retrospectively to document the
occurrence and frequency of documented IART, cardioversion and
arrhythmia-related hospital visits before and after ablation.
Results. Fifty-five catheterizations for intended RF ablation of
IART were performed in 45 patients (mean [6SD] age 24.5 6 10.5
years, 40 after surgical palliation of CHD). Early success was
achieved for one or more IART circuits in 33 patients (73%). Mean
clinical follow-up of those patients with successful ablation is
17.4 6 11.3 months (total 574 patient-months). Documented IART
recurrence was noted after 21 (53%) of 40 early, successful
catheterizations in 17 (52%) of 33 patients, with a mean time to
recurrence of 4.1 months, often with electrocardiographically
novel configurations. A more prolonged and frequent history of
IART was a univariate risk factor for recurrence. Seven patients
underwent repeat RF ablations, and eight patients were restarted
on antiarrhythmic medications after ablation. Two patients who
had severe ventricular dysfunction before RF ablation died 1.5
and 11 months after RF ablation without known arrhythmia
recurrence. Clinical events related to IART increased steadily in
frequency for 24 months before RF ablation. Radiofrequency
ablation resulted in a reduction of event frequency to levels
significantly lower than those in the 12-month period before RF
ablation and not significantly different from those levels observed
at baseline 3 to 4 years before RF ablation.
Conclusions. In patients with successful RF ablation, the
frequency of subsequent events was reduced compared with the 2
preceding years. However, recurrence of IART in patients who
showed clinical improvement was frequent, and often revealed the
presence of new IART configurations.
(J Am Coll Cardiol 1997;30:1032–8)
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Intraatrial reentrant tachycardia (IART) is common after
repair or palliation of many types of congenital heart disease
(CHD), and its prevalence increases over time (1–7). Although
some patients with IART are minimally symptomatic, associ-
ated morbid events may include hemodynamic deterioration,
thromboembolism and death (8–10). Experience with the use
of antiarrhythmic agents and atrial pacing techniques to sup-
press IART or its symptoms has been unsatisfactory (8,11–13).
Early reports of the early efficacy of radiofrequency (RF)
ablation to modify the complex IART substrate in these
patients suggest that this approach, although technically chal-
lenging, may provide a useful alternative therapy (14–16).
The primary purpose of this study was to analyze the
intermediate-term follow-up of IART after RF therapy. Be-
cause the assessment of clinical response to therapeutic inter-
vention in this arrhythmia is complicated by a lack of knowl-
edge of the natural history of recurrent IART, we have also
outlined the time course of well documented clinical events
related to IART experienced by our study patients before RF
ablation, and we have quantified the frequencies of such events
before and after RF ablation.
Methods
Patient selection. The study group was composed of pa-
tients undergoing catheterization for intended RF ablation of
IART at Children’s Hospital of Boston between April 1993
and May 1996. This group included 10 patients in whom the
early efficacy of RF ablation for IART has been previously
reported (14). Additional preprocedural and follow-up data
from this subgroup are included in the current study.
Informed consent for ablation was obtained under a proto-
col approved by the Clinical Investigations Committee of
Children’s Hospital.
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Definition of IART. Intraatrial reentrant tachycardia was
defined as a rapid atrial rhythm that was independent of
atrioventricular conduction, with sudden onset and termina-
tion and a constant cycle length (17). Other electrophysiologic
criteria determined by esophageal or intracardiac study, or
both, confirming the diagnosis included the ability to initiate,
terminate and entrain the tachyarrhythmia using atrial stimu-
lation and the demonstration of a nonsinus mechanism by an
atrial activation sequence. Because multiple configurations of
IART were inducible in some patients, circuits were initially
selected for mapping and ablation if they were similar in
electrocardiographic (ECG) configuration and cycle length to
previously documented tachycardias.
Mapping and ablation technique. The techniques used for
RF ablation of IART were based on those previously reported
(14). Mapping of areas demonstrating abnormal right atrial
conduction were performed both in sinus rhythm and during
IART. Areas of anatomic or functional conduction block, or
both, were identified by observation of split electrograms or
large shifts in electrographic timing associated with small
movements of the mapping catheter, or both. Candidate zones
of slow and/or protected conduction possibly critical to the
IART circuit were identified by the presence of low amplitude,
fractionated electrograms of long duration occurring in atrial
electrical diastole, defined as the period occurring between
surface P waves. These sites were tested using tachycardia
entrainment at rates marginally faster than those of IART.
Postpacing interval and comparison of entrained and sponta-
neous endocardial activation were used to ascertain whether
paced sites lay within the tachycardia circuit and its protected
zone (18). Attempts were made to demonstrate an entrain-
ment response at a variety of anatomic sites, but if the IART
was terminated by entrainment pacing or if sustained IART
had been difficult to induce by programmed stimulation, or
both, entrainment studies were limited to the areas of interest.
Radiofrequency applications were targeted using the demon-
stration of concealed entrainment from a protected zone as a
primary criterion, with secondary criteria including local atrial
mid-diastolic/presystolic activation, fractionated diastolic atrial
electrographic configuration and location in an isthmus be-
tween known anatomic or electrophysiologically identified
areas of conduction block, or both.
Radiofrequency energy was generated using either a
voltage-controlled (Radionics RFG-3C, Radionics, Inc.) or a
temperature-controlled (Medtronic Cardiorhythm Atakr) RF
generator. When RF applications were planned along the
lateral atrial wall, the ability to stimulate the phrenic nerve at
the intended ablation site was assessed by pacing the site at
high output (e.g., 10 mA 3 2 ms) and assessing for the
presence of diaphragmatic twitch. If the phrenic nerve was
easily stimulated, alternate sites were sought. Applications
were made during IART, and if the tachycardia terminated or
became irregular or changed in rate within 15 to 20 s, the
application was continued for 40 to 60 s. Additional lesion(s)
were placed around the anatomic site of a successful ablation
in an effort to increase the lesion size. If the site was thought
to represent an anatomic isthmus, attempts were made to
create a linear lesion between the nonconductive borders.
Attempts were then made to reinduce the ablated IART
using programmed atrial stimulation. Isoproterenol was only
used to increase the sensitivity of postablation testing when a
high likelihood was considered to exist of either incomplete RF
ablation of the targeted circuit or additional clinically relevant
configurations of IART. When additional IART circuits of
different cycle lengths, P wave configuration or activation
sequence, or a combination of these, were identified and
thought to represent clinically relevant tachycardias on the
basis of previous ECG records, endocardial mapping and
ablation procedures were repeated. For the purposes of follow-
up, a successful ablation was defined as termination of one or
more IARTs, including the primary targeted circuit, during RF
application, without the subsequent ability to reinduce those
targeted arrhythmias using programmed stimulation.
Assessment of clinical activity. Because increased fre-
quency of arrhythmia symptoms or the need for early arrhyth-
mia intervention may affect both the quality of the patient’s life
and the perceived need for additional intervention, attempts
were made to quantify the frequency of clinical events per
patient-month before and after early, successful RF ablation.
Review of medical records and procedure notes were used to
ascertain the dates of occurrence of the following types of
events: 1) electrocardiographically documented occurrence of
IART; 2) cardioversion by countershock, pacing or intrave-
nous drug therapy; and 3) emergency room visit or hospital
admission for management of arrhythmia or diagnostic evalu-
ation of symptoms of arrhythmia. Patients and/or their guard-
ians and physicians were interviewed by telephone to ensure
continuous clinical follow-up for all patients to within 3 months
of closure of the study period in November 1996.
Statistical analysis. Statistical analysis was performed us-
ing STATA version 4.0 (Stata Corp.). Dates of clinical events
were converted to time interval (months) before and after RF
ablation of IART; if a second successful RF procedure was
performed, follow-up was referenced to the more recent
procedure. Time intervals were grouped in 12-month periods
ranging from 48 months before the initial RF procedure until
the most recent follow-up visit. Event frequency (events per
patient-month) was determined to be the number of events
occurring in a given period divided by the number of patient-
months of exposure for the entire group in that period. Event
frequency was compared between periods using Poisson re-
gression for comparison of rates. Continuous data are pre-
sented as either mean 6 SD or median (range), as appropriate.
Abbreviations and Acronyms
CHD 5 congestive heart disease
ECG 5 electrocardiographic
IART 5 intraatrial reentrant tachycardia
RF 5 radiofrequency
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Comparison between data sets was performed using the Stu-
dent t test for unpaired data for continuous variables and the
Fisher exact test for categoric variables. Statistical significance
was determined as p , 0.05. Intervals for rates were calculated
for 95% confidence by the binomial exact technique.
Results
Patient characteristics. Forty-five patients (24.5 6 10.5
years [range 7.9 to 44.8]) were catheterized 55 times between
April 1993 and May 1996. Seven patients underwent one or
two repeat ablations for IART at intervals ranging from 9 days
to 34 months. The underlying congenital lesions and surgical
palliations of these patients are presented in Table 1. The
mean age at which definitive cardiac surgical palliation was
performed was 10.4 6 8.1 years (range 0.2 to 26.6), and the
mean age at onset of tachycardia was 16.4 6 9.3 years (range
1.6 to 42.6). Patients had had a median of five documented
episodes of IART before the first attempt at RF ablation
(range 1 to 40). Before a successful ablation, 22 of 33 patients
had undergone a total of 45 trials of antiarrhythmic medication
(mean number of trials 2.0 [range 1 to 7 medications per
patient). Thirteen patients had had implantation of a pacing
system with an atrial pacing lead, and five patients were
programmed in AAIT mode.
Early results of RF ablation. Spontaneous or inducible
IART was present in 43 of 45 patients, with a median of 2
(range 1 to 5) IART circuits identified in each patient. In 41 of
these patients, attempts were made to ablate the IART,
resulting in early termination of 58 IART circuits in 40
catheterizations of 33 patients. Summary data are presented in
Table 2.
Early procedural complications. One patient in whom an
IART circuit was successfully ablated on the lateral wall of the
right atrium suffered prolonged paresis of the right hemidia-
phragm, which was clinically silent and resolved after 3 months.
A second patient had a renal infarction discovered 3 days after
an ablation attempt that did not include catheterization of the
left heart. This resolved without sequela and was presumed to
be secondary to a thromboembolic event associated with
cardioversion from atrial flutter to sinus rhythm at the end of
the ablation attempt. A third patient had femoral venous
cannulation site hemorrhage 6 h after the procedure that
required a 1-U blood transfusion.
Recurrence of IART after RF ablation. IART was docu-
mented electrocardiographically after 21 (53%) of 40 early,
successful RF ablation procedures (confidence interval 36% to
69%) in 17 (52%) of 33 patients (confidence intervals 34% to
69%). Among patients with recurrence, the median time until
first recurrence was 2.1 months (range 1 day to 18.1 months).
Figure 1 presents a Kaplan-Meier analysis for survival free of
documented IART after early, successful RF ablation in this
patient group, and suggests that recurrence is most likely to
occur in the first 6 months after the procedure, with an
actuarial likelihood of freedom from documented arrhythmia
at 3 years of ;40%.
Of the 17 patients with documented recurrence of IART,
seven have undergone 10 additional attempts at RF ablation.
All seven second attempts and none of the three third ablation
attempts had early success. The configurations of the ablated
IARTs in some cases indicated tachycardia mechanisms differ-
ent from those previously ablated (Fig. 2). Ten patients have
required reinstitution or an increase of antiarrhythmic agents,
or both. Of the 16 patients without documented recurrence of
IART, 14 are free of arrhythmia and 2 have had nonsustained
palpitations suggesting undocumented transient recurrence.
Figure 1. Recurrence of documented IART. Kaplan-Meier survival
curve presenting time to first documented IART recurrence in patients
who underwent an early, successful RF ablation for IART. Triangles
represent follow-up in patients free from documented recurrence at
time of study closure.
Table 1. Anatomic Diagnoses and Surgical Procedures
Anatomic
Diagnosis Surgical Procedure
No. (%)
of Patients
Single ventricle Fontan 22 (49%)
TGA Mustard/Senning 8 (18%)
TOF/VSD VSD repair 8 (18%)
ASD ASD repair 2 (4%)
Cardiomyopathy None 2 (4%)
Unrepaired CHD None 2 (4%)
Normal None 1 (2%)
ASD 5 atrial septal defect; CHD 5 congenital heart disease; TGA 5
transposition of the great arteries; TOF 5 tetralogy of Fallot; VSD 5 ventricular
septal defect.
Table 2. Early Success of Radiofrequency Ablation for Intraatrial
Reentrant Tachycardia in Study Group
Patients*
(n 5 45)
Catheterizations*
(n 5 55)
Circuits IART†
(n 5 111)
Spontaneous or induced
IART
43 (96%) 53 (96%) —
Attempted RF ablation of
IART
41 (91%) 50 (91%) 79 (71%)
Successful RF termination
of IART
33 (73%) 40 (73%) 58 (52%)
*Number (%) of patients. †Number (%) of circuits. RF 5 radiofrequency;
IART 5 intraatrial reentrant tachycardia.
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Twelve receive no specific antiarrhythmic therapy and four are
asymptomatic or have minimal symptoms on continued anti-
arrhythmic therapy. On univariate analysis, frequency of prea-
blation IART events was significantly increased in patients who
had IART recurrence. Overall, the frequency of preablation
cardioversions in patients who did not have a subsequent
recurrence was 52% of that seen in patients who subsequently
had a recurrence of IART (0.061 vs. 0.117 cardioversions per
patient-month, p 5 0.0005). Recurrence of IART was not
predicted by type of operation, age at operation, age at RF
ablation, total number of episodes of IART before ablation or
number of IART circuits identified at the time of ablation.
Postprocedure deaths. Two patients, both with severe left
ventricular dysfunction, died suddenly 11 and 1.5 months after
RF ablation without documented recurrence of IART. The
first of these patients had had multiple surgical procedures for
palliation of severe aortic hypoplasia and subaortic stenosis,
and continued to receive multiple antiarrhythmic medications
after RF ablation for IART because of complex ventricular
ectopy and inducible sustained ventricular tachycardia. The
second patient had severe dilated cardiomyopathy associated
with iron overload and hemochromatosis.
Frequency of clinical arrhythmia events before and after
RF ablation. Among patients who had an early, successful RF
ablation, 26 of 33 had clinical records available for a period
$48 months before RF ablation (mean duration of preablation
clinical history 43.0 months). All patients had postablation
follow-up of 17.4 6 11.3 months from the most recent early,
successful RF ablation (range 0.3 to 40.9 months, total posta-
blation exposure 574 patient-months).
The effect of early, successful RF ablation on the frequency
of cardioversions for IART per patient-month of observation is
presented in Figure 3. The study group was divided into
patients in whom a recurrence of documented IART is known
to have occurred and those patients who had not had a
recurrence. Compared with a baseline period 24 to 48 months
before ablation, the frequency of cardioversion increased
steadily during the 24 months before ablation in both groups,
with a marked increase noted in the 12-month period before
ablation. After ablation, the frequency of cardioversion in
those patients with recurrence reverted to a level that was
lower than that experience during the 24 months before
ablation (0.072 vs. 0.181 cardioversions per patient-month, p 5
0.0004) and slightly higher but not significantly different from
that observed during the baseline period (0.072 vs. 0.050
cardioversions per patient-month, p 5 0.347). Similarly, the
frequencies of documented episodes of IART and of hospital
visits also showed a pattern of significant increase during the 24
months before RF ablation. After RF ablation, the frequencies
of both reverted to levels lower than those observed during the
24-month preablation period (0.124 vs. 0.224 episodes of
documented IART per patient-month, p 5 0.005; 0.113 vs.
0.216 hospital visits per patient-month, p 5 0.003), but higher
than those observed during the baseline period 24 to 48
months before ablation (0.124 vs. 0.053 episodes of docu-
mented IART per patient-month, p 5 0.004; 0.113 vs. 0.050
hospital visits per patient-month, p 5 0.008).
Figure 2. Multiple configurations of IART targeted in serial ablation
attempts in one patient. CL 5 cycle length (ms); MAP 5 monophasic
action potential.
Figure 3. Frequency of cardioversion of IART per
patient-month of observation, before and after RF cath-
eter ablation. Cardioversion was defined as direct cur-
rent countershock, overdrive atrial pacing or parenteral
drug therapy, or a combination of these. Data are
separated into two columns for each period, separating
patients who had a documented recurrence of IART
after early, successful RF ablation (dotted bars) from
those who did not (open bars). Before ablation, both
groups experienced a steady increase in the frequency of
cardioversion during the 2 years before RF ablation
attempt(s). Overall preablation event frequency was
higher in patients who subsequently experienced a re-
currence. Among patients who had a recurrence, posta-
blation event frequency was decreased in comparison to
the 2-year period immediately before RF ablation (p 5
0.0004). Postablation event frequency was slightly but
not significantly higher than the frequency computed 3
to 4 years before ablation (p 5 0.347).
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Discussion
The present study documents the intermediate-term results
of RF ablation of IART in a group of patients with CHD.
These results are set in the context of a retrospective review of
clinical arrhythmia activity occurring in this patient group for
the 48 month period preceding an RF ablation attempt, which
revealed a steadily increasing frequency of clinical events
associated with arrhythmia activity (i.e., cardioversion and
arrhythmia-related hospital visits). Radiofrequency ablation
was successfully used to terminate one or more IART circuits
in 73% of patients brought to the catheterization laboratory
with the intention to treat and in 81% of patients in whom an
RF application was actually made. Over a mean follow-up
period of nearly 18 months, IART recurred in 17 (53%) of the
33 patients who had an early, successful RF ablation. Recur-
rence was associated with a higher preablation frequency of
clinical events and usually occurred within 6 months of early,
successful RF ablation. The other 16 patients who had an early,
successful RF ablation have been free of documented recur-
rence of their arrhythmia; this group constitutes 36% of the
original study group of 45 patients. In addition, those patients
who did have arrhythmia recurrence had improvement in their
overall status in comparison to the 2-year period preceding
ablation, as measured by clinical criteria of arrhythmia activity.
Pathogenesis of IART. Intraatrial reentrant tachycardia
complicates the management of many patients with CHD
during the late postoperative period, affecting a large and
increasing percentage of survivors who have undergone a
variety of commonly performed palliative surgical procedures
(1,3,6,7). The frequency with which IART occurs in these
patients, combined with the results of studies that have defined
the experimental substrate needed to initiate and sustain atrial
macroreentrant tachycardias in animals (19–21), suggest that
surgical scarring, fibrosis and hypertrophy of the atrial myo-
cardium are likely to be implicated in its pathogenesis. Studies
of patients who have had the Fontan procedure, who are
particularly prone to IART, have demonstrated a high inci-
dence of sinus node dysfunction and prolonged intraatrial
conduction (22,23). Barriers to conduction that underlie these
prolonged atrial activation times have been demonstrated in
patients with CHD and recurrent IART using high density
mapping techniques (24). The concomitant finding of severe
sinus node dysfunction in many of these patients and the
apparently salutary role of antibradycardia pacing in some
patients (12) suggests that bradycardia may also play an
important role, or at least be an additional marker for likely
occurrence of this arrhythmia. Although IART is not uni-
formly associated with hemodynamic deterioration and may be
clinically asymptomatic, it has also been associated with an
increased risk of thrombosis, congestive heart failure and
death (8–10,25). It was not possible to determine whether the
two deaths in the current study were related to undiagnosed
recurrence of IART. However, their occurrence emphasizes
the severity of global cardiac disease in this patient group.
Frequency and patterns of IART recurrence. Although the
onset of IART has now been well documented (1–3,26), its
natural history after the first occurrence has not been carefully
studied. In the current study, the frequencies of clinical events
attributable to IART increased significantly during the year
before an attempt at RF ablation, with a smaller trend toward
increased frequency noted in the 12 months before that. An
example of this phenomenon is demonstrated in a single
patient (Fig. 4). Although it stands to reason that the frequency
of clinical arrhythmia events is likely to be greatest in any
patient just before the time when a new therapeutic approach
is proposed, the observation of a prolonged rise in such events
extending back 12 to 24 months before the procedure strongly
supports the anecdotal observation that clinical suppression of
IART seems to become more difficult with time. The reason
for this increase in frequency is not evident from these data,
but may reflect continuing slow changes in those features of
the atrial substrate thought to underlie this arrhythmia, such as
fibrosis, hypertrophy and atrial enlargement, worsening sever-
ity of sinus node dysfunction or proarrhythmic effects of other
attempted therapies.
Efficacy of therapies for IART. Studies have suggested that
the efficacy of antiarrhythmic drug therapy (11,13) and atrial
antibradycardia and antitachycardia pacing (12) are of value
only in selected patients, and may be associated with the
potential for lethal complications. Several recent reports have
shown that RF ablation techniques can be used to terminate
IART early on (14–16), but the patient groups have been small
and follow-up duration relatively short. The current study
suggests that, given the current techniques available for map-
ping IART circuits and applying radiofrequency lesions, the
risk of recurrence is high, occurring after about half of early,
successful ablations, with a mean time to recurrence of 4 to 5
months. Although there is no clear control group for patients
in this study, Weindling et al. (11) identified an 80% arrhyth-
mia recurrence rate after 2 years of medical therapy in a larger
group of patients also managed at Children’s Hospital. The
Figure 4. Documented IART episodes in one patient undergoing
three serial RF ablations. In this patient, the first two RF ablations
performed were successful early on at terminating the targeted IART
circuits; the third attempt was unsuccessful. A steady increase in
frequency of arrhythmia events is noted before each ablation attempt.
Arrows indicate dates of ablation, and vertical lines the dates of
documented IART. RFCA 5 radiofrequency catheter ablation.
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frequency of clinical events in the current study was signifi-
cantly decreased when comparing immediate preablation and
postablation periods. Although it is possible that this change
reflects periodic spontaneous variations in IART frequency, it
seems reasonable to interpret this as a real effect of the
ablation procedure. Such a hypothesis is strongly supported by
the patients in the study who have experienced complete or
substantial regression of their IART symptoms after ablation.
Recurrence of IART with different configurations. It was
often difficult to discern clear differences between IARTs
encountered in serial catheterizations. In some cases, however,
it was possible to document clearly the emergence of new
IART configurations at recatheterization. The diversity of
anatomic substrates that may support IART circuits has been
demonstrated by ablation studies in which multiple IARTs are
encountered and by the utilization of several distinct atrial sites
as successful targets for ablation (14,15). More recently, this
diversity has been visualized using high density endocardial
mapping techniques (24). These data allow speculation that
successful ablation of a dominant IART circuit in these
arrhythmia-prone atria may allow the subsequent clinical
emergence of new arrhythmia circuits that are critically depen-
dent on other areas of the atrial myocardium. Possible proar-
rhythmic effects of the RF lesions themselves must also be
considered. Thus, the techniques currently in use to target
vulnerable sites for RF application in specific arrhythmia
circuits may have to be modified to result in a more generalized
modification of the atrial myocardial substrate, as has been
proposed for the prophylaxis of atrial fibrillation (27,28).
Study limitations. Although the patients reported in this
study have been prospectively followed since ablation, docu-
mentation of clinical events before ablation and the choice and
timing of therapeutic interventions varied considerably be-
tween patients. For this reason, the clinical events for review
were chosen to obtain the best available picture of the intensity
of arrhythmia activity, as measured by events that were most
likely to be well documented in the clinical record (cardiover-
sions, hospital admissions). It is unlikely that clinical arrhyth-
mia events, as defined for this study, have occurred without our
knowledge during the follow-up period after ablation, but it is
possible that the preablation history of clinical arrhythmia
events was incomplete for some patients, which could have
decreased our estimates of the frequency of preablation
events. In some cases, multiple therapeutic failures or physi-
cian preference, or both, resulted in long periods of IART
tolerated without a hospital visit or an attempt at cardiover-
sion. Frequency of ECG documentation of IART was used as
a proxy for arrhythmia intensity in these asymptomatic or
minimally symptomatic patients; the results of that analysis
were not different from the analyses of cardioversion or
hospital visits.
An additional limitation of this study is the difficulty in
ascertaining the identity of individual IART circuits electro-
cardiographically, because of slow cycle lengths favoring 1:1
conduction, low P wave amplitudes and unpredictable effects
of previous ablation attempts and passive activation of atrial
tissue on P wave configuration. Although we were able to
demonstrate that recurrent IART circuits clinically distinct
from those ablated could occur (see Fig. 2), in the absence of
careful intracardiac mapping, it was not possible to determine
whether a given IART recurrence represented a new or previ-
ously targeted circuit. Thus, we cannot quantify the relative
importance of inadequate ablation technique versus novel
arrhythmogenesis in determining the frequency of recurrence.
Conclusions. Radiofrequency ablation is a useful adjunct
for the treatment of IART in patients with CHD who are
experiencing frequent arrhythmia recurrences. In this group,
successful RF ablation resulted in good intermediate-term
arrhythmia control in a subset of our study group and in an
overall reduction in the frequency of clinical arrhythmia-
related events observed and treated. However, early and late
recurrence of IART occurred in more than half of the patients
in whom the ablation procedure was deemed “successful” early
on, and new IART circuits frequently presented themselves.
Thus, this targeted RF ablation technique was more likely to
be palliative than curative in this group. Although the electro-
physiology of individual IART circuits indicates that they
possess an excitable gap and are curable by targeted ablation of
an anatomically relevant conductive isthmus, this pattern of
recurrence suggests that a long-term cure or prophylaxis for
this arrhythmia syndrome must address a more complex ar-
rhythmia substrate that has the potential to support multiple
such circuits.
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